Hildegund C.J. Ertl

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Vaccine-induced ICOS<sup>+</sup>CD38<sup>+</sup> circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathway
  2021 L1 88/100

1 assessed by us (1 reproduced) · 302 not yet assessed — every PubMed paper on record, linked below.

• Metabolism of tumor infiltrating T cells ↗

  Frontiers in Immunology · 2026 · PMID 41646971
  not yet assessed
• Rabies glycoprotein engineering for improved stability and expression ↗

  Vaccine · 2025 · PMID 40716142
  not yet assessed
• Human and animal vaccines ↗

  Elsevier eBooks · 2025
  not yet assessed
• A therapeutic HBV vaccine containing a checkpoint modifier enhances CD8+ T cell and antiviral responses ↗

  JCI Insight · 2024 · PMID 39226106
  not yet assessed
• LBP-018 Promising first-in-human, first-in-class, Phase 1B immunogenicity data of VRON-0200, a novel checkpoint modifier containing immunotherapy, for HBV functional cure ↗

  Journal of Hepatology · 2024
  not yet assessed
• Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression ↗

  Drugs · 2023 · PMID 36715794
  not yet assessed
• Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice ↗

  npj Vaccines · 2023 · PMID 36823425
  not yet assessed
• Circumventing B Cell Responses to Allow for Redosing of Adeno-Associated Virus Vectors ↗

  Human Gene Therapy · 2023 · PMID 37861281
  not yet assessed
• Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8+ T cell therapy for melanoma ↗

  Molecular Therapy — Oncolytics · 2023 · PMID 38075243
  not yet assessed
• Lyssaviruses and Rabies Vaccines ↗

  Elsevier eBooks · 2023
  not yet assessed
• Supplemental Figure 1 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Data from Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a <i>Recombinant DNA Advisory Committee Symposium</i> Held June 15, 2010 ↗

  2023
  not yet assessed
• Data from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Supplementary Tables 1-5 from Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a <i>Recombinant DNA Advisory Committee Symposium</i> Held June 15, 2010 ↗

  2023
  not yet assessed
• Supplementary References from Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a <i>Recombinant DNA Advisory Committee Symposium</i> Held June 15, 2010 ↗

  2023
  not yet assessed
• Supplemental Figure 5 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Supplemental Figure 6 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Supplemental Figure 4 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Supplemental Figure 2 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Supplemental Figure 3 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Supplementary References from Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a <i>Recombinant DNA Advisory Committee Symposium</i> Held June 15, 2010 ↗

  2023
  not yet assessed
• Supplemental Figure 1 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Supplemental Figure 6 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Supplemental Figure 3 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Supplemental Figure 4 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Supplemental Figure 2 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Supplemental Figure 5 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Historical Progression from Nerve Tissue-Based Rabies Vaccines to Recombinant Biologics for Humans and Companion Animals ↗

  Fascinating life sciences · 2023
  not yet assessed
• Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for <i>Human Gene Therapy</i> ↗

  Human Gene Therapy · 2023
  not yet assessed
• Intrahepatic CD8+ T cells correlate with significant declines in HBV viral load and S antigen following a single vaccination with VRON-0200 in an AAV mouse model ↗

  Journal of Hepatology · 2023
  not yet assessed
• Contributors ↗

  Elsevier eBooks · 2023
  not yet assessed
• Peptides as Molecular Probes of Immune Responses ↗

  2023
  not yet assessed
• 454 Checkpoint modification of early T cell activation provides enhanced anti-tumor activity and survival benefits in a fast-growing preclinical tumor challenge model ↗

  Regular and Young Investigator Award Abstracts · 2023
  not yet assessed
• Data from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  2023
  not yet assessed
• Data from Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a &lt;i&gt;Recombinant DNA Advisory Committee Symposium&lt;/i&gt; Held June 15, 2010 ↗

  2023
  not yet assessed
• Immunogenicity and toxicity of AAV gene therapy ↗

  Frontiers in Immunology · 2022 · PMID 36032092
  not yet assessed
• Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection ↗

  Journal of Hepatology · 2022 · PMID 35259469
  not yet assessed
• The Effect of Rapamycin and Ibrutinib on Antibody Responses to Adeno-Associated Virus Vector-Mediated Gene Transfer ↗

  Human Gene Therapy · 2022 · PMID 35229644
  not yet assessed
• A One Medicine Mission for an Effective Rabies Therapy ↗

  Frontiers in Veterinary Science · 2022 · PMID 35372555
  not yet assessed
• Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19 ↗

  Microbes and Infection · 2022 · PMID 36539010
  not yet assessed
• COVID-19 vaccination and HIV-1 acquisition ↗

  The Lancet · 2022 · PMID 35397866
  not yet assessed
• Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19? ↗

  Frontiers in Public Health · 2022 · PMID 35769785
  not yet assessed
• 16P Checkpoint modification of BTLA-HVEM-LIGHT signaling by HSV-1 glycoprotein D (gD) improves vaccine-induced CD8+ T cell responses in pre-clinical cancer models ↗

  Annals of Oncology · 2022
  not yet assessed
• Pre-clinical testing of two serologically distinct chimpanzee-origin adenovirus vectors expressing spike of SARS-CoV-2 ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2022
  not yet assessed
• Prime-boost vaccinations with two serologically distinct chimpanzee adenovirus vectors expressing SARS-CoV-2 spike or nucleocapsid tested in a hamster COVID-19 model ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2022
  not yet assessed
• Pre-Clinical Testing of Two Serologically Distinct Chimpanzee-Origin Adenovirus Vectors Expressing Spike of SARS-CoV-2 ↗

  SSRN Electronic Journal · 2022
  not yet assessed
• T Cell-Mediated Immune Responses to AAV and AAV Vectors ↗

  Frontiers in Immunology · 2021 · PMID 33927727
  not yet assessed
• Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways

  Cell Reports Medicine · 2021 · PMID 34095875
  L1 88/100
• COVID-19 Vaccines Based on Adenovirus Vectors ↗

  Trends in Biochemical Sciences · 2021 · PMID 33810926
  not yet assessed
• T cell responses to adenoviral vectors expressing the SARS-CoV-2 nucleoprotein. ↗

  PubMed · 2021 · PMID 35903088
  not yet assessed
• Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection ↗

  Virology Journal · 2021 · PMID 34876153
  not yet assessed
• The natural stilbenoid (–)-hopeaphenol inhibits cellular entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7 and B.1.351 variants ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2021
  not yet assessed
• Review of: "Systemic and local immune response to intraocular AAV vector administration in non-human primates" ↗

  2021
  not yet assessed
• PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy ↗

  Cancer Research · 2021 · PMID 34244236
  not yet assessed
• Towards rabies elimination in the Asia-Pacific region: From theory to practice ↗

  Biologicals · 2020 · PMID 32089431
  not yet assessed
• T and B Cell Metabolism in Older Adults ↗

  Immunometabolism · 2020
  not yet assessed
• Immunogenicity and efficacy of an HBV vaccine with an intrinsic checkpoint inhibitor ↗

  Journal of Hepatology · 2020
  not yet assessed
• Human and animal vaccines ↗

  Elsevier eBooks · 2020
  not yet assessed
• Next generation of rabies vaccines ↗

  Elsevier eBooks · 2020
  not yet assessed
• Glycoprotein D, a checkpoint inhibitor of early T-cell activation, to improve immunogenicity and efficacy of an HPV-16 vaccine in preclinical studies. ↗

  Journal of Clinical Oncology · 2020
  not yet assessed
• Novel Rabies Vaccines ↗

  2020
  not yet assessed
• Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals ↗

  Cell Host & Microbe · 2019 · PMID 30795982
  not yet assessed
• The Effect of CpG Sequences on Capsid-Specific CD8+ T Cell Responses to AAV Vector Gene Transfer ↗

  Molecular Therapy · 2019 · PMID 31839483
  not yet assessed
• New Rabies Vaccines for Use in Humans ↗

  Vaccines · 2019 · PMID 31226750
  not yet assessed
• Age-related changes in B cell metabolism ↗

  Aging · 2019 · PMID 31283526
  not yet assessed
• Avoiding preventable deaths: The scourge of counterfeit rabies vaccines ↗

  Vaccine · 2019 · PMID 30922698
  not yet assessed
• Recombinant Adenovirus Vectors as Mucosal Vaccines ↗

  Elsevier eBooks · 2019
  not yet assessed
• Vaccine-induced ICOS+CD38+ cTfh are sensitive biosensors of age-related changes in inflammatory pathways ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2019
  not yet assessed
• List of Contributors ↗

  Elsevier eBooks · 2019
  not yet assessed
• Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012–2013 ↗

  Clinical Infectious Diseases · 2018 · PMID 29471464
  not yet assessed
• A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis ↗

  PLoS neglected tropical diseases · 2018 · PMID 30372438
  not yet assessed
• Immune response to influenza vaccination in the elderly is altered by chronic medication use ↗

  Immunity & Ageing · 2018 · PMID 30186359
  not yet assessed
• New human rabies vaccines in the pipeline ↗

  Vaccine · 2018 · PMID 30153997
  not yet assessed
• Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge ↗

  Scientific Reports · 2018 · PMID 29348479
  not yet assessed
• Additional Progress in the Development and Application of a Direct, Rapid Immunohistochemical Test for Rabies Diagnosis ↗

  Veterinary Sciences · 2018 · PMID 29925781
  not yet assessed
• Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors ↗

  EBioMedicine · 2018 · PMID 29685793
  not yet assessed
• Human immune responses to traditional and novel rabies vaccines ↗

  Revue Scientifique et Technique de l OIE · 2018 · PMID 30747120
  not yet assessed
• Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma ↗

  Cancer Immunology Immunotherapy · 2018 · PMID 30051333
  not yet assessed
• Coaching tumor-infiltrating CD8+ T cells to eat right ↗

  Oncoscience · 2018 · PMID 29556509
  not yet assessed
• A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2018
  not yet assessed
• Erratum: Rupprecht, C.E., et al. Additional Progress in the Development and Application of a Direct, Rapid Immunohistochemical Test for Rabies Diagnosis. Vet. Sci. 2018, 5, 59 ↗

  Veterinary Sciences · 2018 · PMID 30036969
  not yet assessed
• Coaching tumor-infiltrating CD8+ T cells to eat right ↗

  Oncoscience · 2018
  not yet assessed
• Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy ↗

  Cancer Cell · 2017 · PMID 28898698
  not yet assessed
• Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy ↗

  Human Gene Therapy · 2017 · PMID 28042943
  not yet assessed
• The effect of timing of influenza vaccination and sample collection on antibody titers and responses in the aged ↗

  Vaccine · 2017 · PMID 28583307
  not yet assessed
• Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in vivo ↗

  Vaccine · 2017 · PMID 28438408
  not yet assessed
• Preclinical models to assess the immunogenicity of AAV vectors ↗

  Cellular Immunology · 2017 · PMID 29195742
  not yet assessed
• Rabies Vaccines ↗

  Elsevier eBooks · 2017
  not yet assessed
• An Opinion on Routine Rabies Pre-Exposure Prophylaxis for Children in High Endemic Areas ↗

  Journal of Vaccines & Vaccination · 2017
  not yet assessed
• Despite egg-adaptive mutations, the 2012-13 H3N2 influenza vaccine induced comparable antibody titers to the intended strain ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2017
  not yet assessed
• Homologous and heterologous prime boost vaccinations with distinct variants of Plasmodium vivax circumsporozoite protein (CSP) protects mice against transgenic PB/PV sporozoite challenge

  Oxford University Research Archive (ORA) (University of Oxford) · 2017
  not yet assessed
• Contributors ↗

  Elsevier eBooks · 2017
  not yet assessed
• Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid ↗

  Molecular Therapy · 2016 · PMID 27019999
  not yet assessed
• Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors ↗

  Oncotarget · 2016 · PMID 26943036
  not yet assessed
• Starved and Asphyxiated: How Can CD8+ T Cells within a Tumor Microenvironment Prevent Tumor Progression ↗

  Frontiers in Immunology · 2016 · PMID 26904023
  not yet assessed
• Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood ↗

  Oncotarget · 2016 · PMID 27588486
  not yet assessed
• Viral vectors as vaccine carriers ↗

  Current Opinion in Virology · 2016 · PMID 27327517
  not yet assessed
• Current Status and Development of Vaccines and Other Biologics for Human Rabies Prevention ↗

  Expert Review of Vaccines · 2016 · PMID 26796599
  not yet assessed
• Vaccine Design: Replication-Defective Adenovirus Vectors ↗

  Methods in molecular biology · 2016 · PMID 27076309
  not yet assessed
• Age-related changes in the transcriptome of antibody-secreting cells ↗

  Oncotarget · 2016 · PMID 26967249
  not yet assessed
• Rapid, Efficient, and Modular Generation of Adenoviral Vectors via Isothermal Assembly ↗

  Current Protocols in Molecular Biology · 2016 · PMID 31773916
  not yet assessed
• Antibody responses to prime–boost vaccination with an HIV-1 gp145 envelope protein and chimpanzee adenovirus vectors expressing HIV-1 gp140 ↗

  AIDS · 2016 · PMID 27525550
  not yet assessed
• Aging: T cell metabolism within tumors ↗

  Aging · 2016 · PMID 27282177
  not yet assessed
• Age-related changes in the gene expression profile of antigen-specific mouse CD8+ T cells can be partially reversed by blockade of the BTLA/CD160 pathways during vaccination ↗

  Aging · 2016 · PMID 27922818
  not yet assessed
• A Partial <i>E3</i> Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products ↗

  Human Gene Therapy Methods · 2016 · PMID 27604324
  not yet assessed
• Adenoviral Vector Vaccines Antigen Transgene ↗

  Elsevier eBooks · 2016
  not yet assessed
• Fatty acid metabolism is essential to maintain functions of CD8+T cells within a hypoxic and hypoglycemic tumor microenvironment ↗

  The Journal of Immunology · 2016
  not yet assessed
• Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene Transfer ↗

  Journal of Innate Immunity · 2015 · PMID 25612611
  not yet assessed
• AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes ↗

  Molecular Therapy — Methods & Clinical Development · 2015 · PMID 26445723
  not yet assessed
• Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection ↗

  Mucosal Immunology · 2015 · PMID 25872483
  not yet assessed
• Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation ↗

  Journal of Virology · 2015 · PMID 25995265
  not yet assessed
• BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine ↗

  Oncotarget · 2015 · PMID 26277622
  not yet assessed
• A shortened interval between vaccinations with the trivalent inactivated influenza vaccine increases responsiveness in the aged ↗

  Aging · 2015 · PMID 26637961
  not yet assessed
• Abstract B49: Metabolic stress within tumors lead to exhaustion of melanoma antigen-specific CD8+ T cells ↗

  Cancer Immunology Research · 2015
  not yet assessed
• Gene therapy and gene transfer approaches to prevent or treat chronic virus infections. ↗

  PubMed · 2015 · PMID 26034787
  not yet assessed
• Circulating CXCR5+PD-1+ Response Predicts Influenza Vaccine Antibody Responses in Young Adults but not Elderly Adults ↗

  The Journal of Immunology · 2014 · PMID 25172499
  not yet assessed
• Activated CD4 ⁺ CCR5 ⁺ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques ↗

  Proceedings of the National Academy of Sciences · 2014 · PMID 25550504
  not yet assessed
• Protection of non-human primates against rabies with an adenovirus recombinant vaccine ↗

  Virology · 2014 · PMID 24503087
  not yet assessed
• Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B ↗

  Journal of Translational Medicine · 2014 · PMID 24460861
  not yet assessed
• Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models ↗

  Molecular Therapy — Nucleic Acids · 2014 · PMID 25368912
  not yet assessed
• The Effect of Adjuvanting Cancer Vaccines with Herpes Simplex Virus Glycoprotein D on Melanoma-Driven CD8+ T Cell Exhaustion ↗

  The Journal of Immunology · 2014 · PMID 25024391
  not yet assessed
• Adenovirus-Based Vaccines against Rhesus Lymphocryptovirus EBNA-1 Induce Expansion of Specific CD8 ⁺ and CD4 ⁺ T Cells in Persistently Infected Rhesus Macaques ↗

  Journal of Virology · 2014 · PMID 24522914
  not yet assessed
• The effect of adenovirus-specific antibodies on adenoviral vector–induced, transgene product–specific T cell responses ↗

  Journal of Leukocyte Biology · 2014 · PMID 25082150
  not yet assessed
• Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose ↗

  Retrovirology · 2014 · PMID 24444350
  not yet assessed
• Enhancement of recombinant adenovirus vaccine-induced primary but not secondary systemic and mucosal immune responses by all-trans retinoic acid ↗

  Vaccine · 2014 · PMID 24780251
  not yet assessed
• Adenoviral Vectors as Vaccine Carriers for Prevention of Rabies ↗

  Elsevier eBooks · 2014
  not yet assessed
• Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not older adults (VAC2P.936) ↗

  The Journal of Immunology · 2014
  not yet assessed
• List of Contributors ↗

  Elsevier eBooks · 2014
  not yet assessed
• Immunogenicity of a Prime-Boost Vaccine Containing the Circumsporozoite Proteins of Plasmodium vivax in Rodents ↗

  Infection and Immunity · 2013 · PMID 24478093
  not yet assessed
• Vaccine-Induced Boosting of Influenza Virus-Specific CD4 T Cells in Younger and Aged Humans ↗

  PLoS ONE · 2013 · PMID 24155927
  not yet assessed
• CD8+ T Cell Recognition of Epitopes Within the Capsid of Adeno-associated Virus 8–based Gene Transfer Vectors Depends on Vectors’ Genome ↗

  Molecular Therapy · 2013 · PMID 24077034
  not yet assessed
• CD4⁺and CD8⁺T-Cell Responses to Latent Antigen EBNA-1 and Lytic Antigen BZLF-1 during Persistent Lymphocryptovirus Infection of Rhesus Macaques ↗

  Journal of Virology · 2013 · PMID 23698300
  not yet assessed
• Influenza Virus Specific CD8⁺T Cells Exacerbate Infection Following High Dose Influenza Challenge of Aged Mice ↗

  BioMed Research International · 2013 · PMID 24187666
  not yet assessed
• Effects of Immunosuppression on Circulating Adeno-Associated Virus Capsid-Specific T cells in Humans ↗

  Human Gene Therapy · 2013 · PMID 23461589
  not yet assessed
• Immunological and Virological Analyses of Rhesus Macaques Immunized with Chimpanzee Adenoviruses Expressing the Simian Immunodeficiency Virus Gag/Tat Fusion Protein and Challenged Intrarectally with Repeated Low Doses of SIVmac ↗

  Journal of Virology · 2013 · PMID 23804645
  not yet assessed
• B cell responses to the 2011/12-influenza vaccine in the aged ↗

  Aging · 2013 · PMID 23674565
  not yet assessed
• Therapeutic Vaccination against the Rhesus Lymphocryptovirus EBNA-1 Homologue, rhEBNA-1, Elicits T Cell Responses to Novel Epitopes in Rhesus Macaques ↗

  Journal of Virology · 2013 · PMID 24089556
  not yet assessed
• Next Generation of Rabies Vaccines ↗

  Elsevier eBooks · 2013
  not yet assessed
• Recombinant Vaccine to HIV-1 Gag A Simian Replication-Defective Adenoviral

  2013
  not yet assessed
• Defective CD8 T Cell Responses in Aged Mice Are Due to Quantitative and Qualitative Changes in Virus-Specific Precursors ↗

  The Journal of Immunology · 2012 · PMID 22246631
  not yet assessed
• Hexon-modified Recombinant E1-deleted Adenovirus Vectors as Dual Specificity Vaccine Carriers for Influenza Virus ↗

  Molecular Therapy · 2012 · PMID 23229092
  not yet assessed
• Preventative childhood vaccination to rabies ↗

  Expert Opinion on Biological Therapy · 2012 · PMID 22724389
  not yet assessed
• Correlates of relative resistance against low-dose rectal simian immunodeficiency virus challenges in peripheral blood mononuclear cells of vaccinated rhesus macaques ↗

  Journal of Leukocyte Biology · 2012 · PMID 23271702
  not yet assessed
• Gene Therapy Research at the Frontiers of Viral Immunology ↗

  Frontiers in Microbiology · 2012 · PMID 22783235
  not yet assessed
• Progress in the Development of Hepatitis C Virus Vaccines ↗

  Molecular Therapy · 2012 · PMID 22472980
  not yet assessed
• Advances in virus research 79: research advances in rabies ↗

  The Lancet Infectious Diseases · 2012
  not yet assessed
• The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9–dependent innate immune responses in the liver ↗

  Blood · 2011 · PMID 21474674
  not yet assessed
• Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a <i>Recombinant DNA Advisory Committee Symposium</i> Held June 15, 2010 ↗

  Cancer Research · 2011 · PMID 21531763
  not yet assessed
• Capsid-specific T-cell Responses to Natural Infections With Adeno-associated Viruses in Humans Differ From Those of Nonhuman Primates ↗

  Molecular Therapy · 2011 · PMID 21587208
  not yet assessed
• Self-complementary AAVs Induce More Potent Transgene Product-specific Immune Responses Compared to a Single-stranded Genome ↗

  Molecular Therapy · 2011 · PMID 22186792
  not yet assessed
• Active Immunotherapy Combined With Blockade of a Coinhibitory Pathway Achieves Regression of Large Tumor Masses in Cancer-prone Mice ↗

  Molecular Therapy · 2011 · PMID 21587210
  not yet assessed
• Viruses—from pathogens to vaccine carriers ↗

  Current Opinion in Virology · 2011 · PMID 22003377
  not yet assessed
• Effect of Preexisting Immunity to Adenovirus on Transgene Product-Specific Genital T Cell Responses on Vaccination of Mice With a Homologous Vector ↗

  The Journal of Infectious Diseases · 2011 · PMID 21450997
  not yet assessed
• The Ideal Vaccine: Until Death Do Us Part ↗

  Molecular Therapy · 2011 · PMID 21532607
  not yet assessed
• Can Viruses be Modified to Achieve Sustained Gene Transfer ↗

  Frontiers in Microbiology · 2011 · PMID 21808636
  not yet assessed
• Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of <i>Adenoviridae</i> ↗

  Journal of Virology · 2010 · PMID 20686035
  not yet assessed
• Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive ↗

  Vaccine · 2010 · PMID 20188249
  not yet assessed
• Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys ↗

  Virology · 2010 · PMID 20797754
  not yet assessed
• Cell-Intrinsic Defects in the Proliferative Response of Antiviral Memory CD8 T Cells in Aged Mice upon Secondary Infection ↗

  The Journal of Immunology · 2010 · PMID 20368274
  not yet assessed
• An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector ↗

  Nature Protocols · 2010 · PMID 21030953
  not yet assessed
• A Universal Influenza A Vaccine Based on Adenovirus Expressing Matrix-2 Ectodomain and Nucleoprotein Protects Mice From Lethal Challenge ↗

  Molecular Therapy · 2010 · PMID 20877342
  not yet assessed
• Immune Responses and Therapeutic Antitumor Effects of an Experimental DNA Vaccine Encoding Human Papillomavirus Type 16 Oncoproteins Genetically Fused to Herpesvirus Glycoprotein D ↗

  Clinical and Vaccine Immunology · 2010 · PMID 20739505
  not yet assessed
• Adeno-associated Virus Vectors Serotype 2 Induce Prolonged Proliferation of Capsid-Specific CD8+ T Cells in Mice ↗

  Molecular Therapy · 2010 · PMID 21157435
  not yet assessed
• Augmentation of Primary Influenza A Virus-Specific CD8+ T Cell Responses in Aged Mice through Blockade of an Immunoinhibitory Pathway ↗

  The Journal of Immunology · 2010 · PMID 20410485
  not yet assessed
• Targeting inhibitory pathways in cancer immunotherapy ↗

  Current Opinion in Immunology · 2010 · PMID 20466529
  not yet assessed
• Robust genital gag‐specific CD8⁺ T‐cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV‐1‐gag ↗

  European Journal of Immunology · 2010 · PMID 21108465
  not yet assessed
• Vaccination with Ad5 Vectors Expands Ad5-Specific CD8+ T Cells without Altering Memory Phenotype or Functionality ↗

  PLoS ONE · 2010 · PMID 21203546
  not yet assessed
• Vaccine-induced T cells Provide Partial Protection Against High-dose Rectal SIVmac239 Challenge of Rhesus Macaques ↗

  Molecular Therapy · 2010 · PMID 21081905
  not yet assessed
• Simian recombinant adenovirus delivered by the mucosal route modulates γδ T cells from murine genital tract ↗

  Vaccine · 2010 · PMID 20460181
  not yet assessed
• Introduction ↗

  Current Opinion in Immunology · 2010 · PMID 20510596
  not yet assessed
• New Insights on Adenovirus as Vaccine Vectors ↗

  Molecular Therapy · 2009 · PMID 19513019
  not yet assessed
• Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans ↗

  PLoS neglected tropical diseases · 2009 · PMID 19888334
  not yet assessed
• Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells ↗

  Nature Medicine · 2009 · PMID 19620962
  not yet assessed
• Novel Vaccines to Human Rabies ↗

  PLoS neglected tropical diseases · 2009 · PMID 19787033
  not yet assessed
• Impact of the Underlying Mutation and the Route of Vector Administration on Immune Responses to Factor IX in Gene Therapy for Hemophilia B ↗

  Molecular Therapy · 2009 · PMID 19603001
  not yet assessed
• Effect of Preexisting Immunity on an Adenovirus Vaccine Vector: In Vitro Neutralization Assays Fail To Predict Inhibition by Antiviral Antibody In Vivo ↗

  Journal of Virology · 2009 · PMID 19279092
  not yet assessed
• Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors ↗

  Vaccine · 2009 · PMID 19660588
  not yet assessed
• Adenovirus Vector-Induced Immune Responses in Nonhuman Primates: Responses to Prime Boost Regimens ↗

  The Journal of Immunology · 2009 · PMID 19414814
  not yet assessed
• A Preclinical Animal Model to Assess the Effect of Pre-existing Immunity on AAV-mediated Gene Transfer ↗

  Molecular Therapy · 2009 · PMID 19367258
  not yet assessed
• Pandemic Influenza Vaccines ↗

  Current topics in microbiology and immunology · 2009 · PMID 19768412
  not yet assessed
• Potentiating vaccine immunogenicity by manipulating the HVEM/BTLA pathway and other co-stimulatory and co-inhibitory signals of the immune system ↗

  Human Vaccines · 2009 · PMID 18927514
  not yet assessed
• Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine ↗

  Journal of Leukocyte Biology · 2009 · PMID 19597003
  not yet assessed
• The RAC: Double, Double, Toil, and Trouble? ↗

  Molecular Therapy · 2009 · PMID 19247363
  not yet assessed
• Correction: Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans ↗

  PLoS neglected tropical diseases · 2009
  not yet assessed
• Single‐dose immunogenicity and protective efficacy of simian adenoviral vectors against <i>Plasmodium berghei</i> ↗

  European Journal of Immunology · 2008 · PMID 18266272
  not yet assessed
• Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses ↗

  Nature Medicine · 2008 · PMID 18193057
  not yet assessed
• Immune barriers to successful gene therapy ↗

  Trends in Molecular Medicine · 2008 · PMID 19101205
  not yet assessed
• Safety of Adeno-Associated Viral Vectors ↗

  Future Virology · 2008
  not yet assessed
• Compromised CD8 T cell recall responses in the aged mice ↗

  The FASEB Journal · 2008
  not yet assessed
• New vectored vaccines for malaria.

  International Journal for Parasitology · 2008
  not yet assessed
• CD8+ T-cell responses to adeno-associated virus capsid in humans ↗

  Nature Medicine · 2007 · PMID 17369837
  not yet assessed
• Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines ↗

  Blood · 2007 · PMID 17510320
  not yet assessed
• Effect of Preexisting Immunity to Adenovirus Human Serotype 5 Antigens on the Immune Responses of Nonhuman Primates to Vaccine Regimens Based on Human- or Chimpanzee-Derived Adenovirus Vectors ↗

  Journal of Virology · 2007 · PMID 17428852
  not yet assessed
• Pre-existing AAV Capsid-specific CD8+ T Cells are Unable to Eliminate AAV-transduced Hepatocytes ↗

  Molecular Therapy · 2007 · PMID 17245353
  not yet assessed
• Type I Interferon Inhibits Antibody Responses Induced by a Chimpanzee Adenovirus Vector ↗

  Molecular Therapy · 2007 · PMID 17235319
  not yet assessed
• Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing ↗

  Virology · 2007 · PMID 17590405
  not yet assessed
• Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response ↗

  Nature Medicine · 2006 · PMID 16474400
  not yet assessed
• Random migration precedes stable target cell interactions of tumor-infiltrating T cells ↗

  The Journal of Experimental Medicine · 2006 · PMID 17116735
  not yet assessed
• Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa ↗

  Emerging infectious diseases · 2006 · PMID 17176582
  not yet assessed
• Structure-Based Identification of a Major Neutralizing Site in an Adenovirus Hexon ↗

  Journal of Virology · 2006 · PMID 17108028
  not yet assessed
• A Chimpanzee-Origin Adenovirus Vector Expressing the Rabies Virus Glycoprotein as an Oral Vaccine against Inhalation Infection with Rabies Virus ↗

  Molecular Therapy · 2006 · PMID 16797238
  not yet assessed
• Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut ↗

  Vaccine · 2006 · PMID 17229501
  not yet assessed
• Trichostatin-A enhances adaptive immune responses to DNA vaccination ↗

  Journal of Clinical Virology · 2006 · PMID 16765083
  not yet assessed
• Cyclosporin A Provides No Sustained Immunologic Benefit to Persons with Chronic HIV‐1 Infection Starting Suppressive Antiretroviral Therapy: Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138 ↗

  The Journal of Infectious Diseases · 2006 · PMID 17109339
  not yet assessed
• Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus ↗

  Vaccine · 2006 · PMID 16914235
  not yet assessed
• AAV-2 Capsid-Specific CD8+ T Cells Limit the Duration of Gene Therapy in Humans and Cross-React with AAV-8 Capsid. ↗

  Blood · 2006
  not yet assessed
• Erratum: CORRIGENDUM: Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response ↗

  Nature Medicine · 2006
  not yet assessed
• Chimpanzee-origin adenovirus vectors as vaccine carriers ↗

  Gene Therapy · 2005 · PMID 16319951
  not yet assessed
• Identification of mouse AAV capsid-specific CD8+ T cell epitopes ↗

  Molecular Therapy · 2005 · PMID 16263332
  not yet assessed
• Dendritic Cell Maturation, but Not CD8+ T Cell Induction, Is Dependent on Type I IFN Signaling during Vaccination with Adenovirus Vectors ↗

  The Journal of Immunology · 2005 · PMID 16237098
  not yet assessed
• Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1 ↗

  Microbes and Infection · 2005 · PMID 16213178
  not yet assessed
• Therapeutic potential of adenovirus as a vaccine vector for chronic virus infections ↗

  Expert Opinion on Biological Therapy · 2005 · PMID 16370915
  not yet assessed
• Adenoviral Gene Delivery for HIV-1 Vaccination ↗

  Current Gene Therapy · 2005 · PMID 15853728
  not yet assessed
• Immunological insights from genetic vaccines ↗

  Virus Research · 2005 · PMID 15896407
  not yet assessed
• Challenges of immune responses in gene replacement therapy. ↗

  PubMed · 2005 · PMID 16118696
  not yet assessed
• Adenoviruses as vaccine vectors ↗

  Molecular Therapy · 2004 · PMID 15451446
  not yet assessed
• CpG Methylation of a Plasmid Vector Results in Extended Transgene Product Expression by Circumventing Induction of Immune Responses ↗

  Molecular Therapy · 2004 · PMID 14759809
  not yet assessed
• Human Immunodeficiency Virus Type 1-Specific Immune Responses in Primates upon Sequential Immunization with Adenoviral Vaccine Carriers of Human and Simian Serotypes ↗

  Journal of Virology · 2004 · PMID 15220412
  not yet assessed
• DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins ↗

  Cancer Gene Therapy · 2004 · PMID 15118761
  not yet assessed
• Identification of the AAV2 Capsid CD8+ T Cell Epitope in C57BL/6 Mice. ↗

  Blood · 2004
  not yet assessed
• Rabies Vaccines: The Third Generation ↗

  Letters in Drug Design & Discovery · 2004
  not yet assessed
• Management of Rabies in Humans ↗

  Clinical Infectious Diseases · 2003 · PMID 12491203
  not yet assessed
• A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag ↗

  The Journal of Immunology · 2003 · PMID 12538702
  not yet assessed
• Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier ↗

  Journal of Virology · 2003 · PMID 14512528
  not yet assessed
• Induction of CD8+ T Cells to an HIV-1 Antigen through a Prime Boost Regimen with Heterologous E1-Deleted Adenoviral Vaccine Carriers ↗

  The Journal of Immunology · 2003 · PMID 14662882
  not yet assessed
• A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma ↗

  Cancer Gene Therapy · 2003 · PMID 12944987
  not yet assessed
• Mucosally Delivered E1-Deleted Adenoviral Vaccine Carriers Induce Transgene Product-Specific Antibody Responses in Neonatal Mice ↗

  The Journal of Immunology · 2003 · PMID 14530353
  not yet assessed
• Vaccine-induced CD8+ T cells eliminate tumors by a two-staged attack ↗

  Cancer Gene Therapy · 2003 · PMID 14712313
  not yet assessed
• Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus ↗

  Cellular Immunology · 2003 · PMID 14609576
  not yet assessed
• Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector ↗

  Vaccine · 2003 · PMID 14741162
  not yet assessed
• Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost ↗

  Journal of General Virology · 2003 · PMID 12533717
  not yet assessed
• Rabies DNA vaccines for protection and therapeutic treatment ↗

  Expert Opinion on Biological Therapy · 2003 · PMID 12831368
  not yet assessed
• T Helper Cell-Independent Antibody Responses to the Transgene Product of an E1-Deleted Adenoviral Vaccine Require NK1.1 T Cells ↗

  Virology · 2003 · PMID 12573585
  not yet assessed
• Activation of the Innate Immune System by DNA Vaccines ↗

  2003
  not yet assessed
• Rabies DNA vaccines for protection and therapeutic treatment ↗

  Expert Opinion on Biological Therapy · 2003
  not yet assessed
• Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product ↗

  Journal of Virology · 2002 · PMID 11861833
  not yet assessed
• A dendritic cell vaccine induces protective immunity to intracranial growth of glioma. ↗

  PubMed · 2002 · PMID 12014629
  not yet assessed
• Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor ↗

  Journal of General Virology · 2002 · PMID 11752711
  not yet assessed
• Rabies Vaccines: From the Past to the 21st Century ↗

  Hybridoma and Hybridomics · 2002 · PMID 12031102
  not yet assessed
• Synthesis, Conformation and T-Helper Cell Stimulation of an O-Linked Glycopeptide Epitope Containing Extended Carbohydrate Side-Chains ↗

  Bioorganic & Medicinal Chemistry · 2002 · PMID 12413838
  not yet assessed
• A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line ↗

  Cellular Immunology · 2002 · PMID 12142033
  not yet assessed
• Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein ↗

  Veterinary Microbiology · 2002 · PMID 11856579
  not yet assessed
• An Experimental Vaccine Expressing Wild‐Type p53 Induces Protective Immunity against Glioblastoma Cells with High Levels of Endogenous p53 ↗

  Scandinavian Journal of Immunology · 2002 · PMID 12234257
  not yet assessed
• Low scale multiple array synthesis and DNA hybridization of peptide nucleic acids ↗

  2002
  not yet assessed
• Phosphopeptide models of the C-terminal basic domain of p53 ↗

  2002
  not yet assessed
• In situ identification of T helper cell epitopes from a cellulose-bound peptide array ↗

  2002
  not yet assessed
• Replication-Defective Vector Based on a Chimpanzee Adenovirus ↗

  Journal of Virology · 2001 · PMID 11689642
  not yet assessed
• DNA Vaccines. ↗

  Current Molecular Medicine · 2001 · PMID 11899073
  not yet assessed
• Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16 ↗

  Vaccine · 2001 · PMID 11348726
  not yet assessed
• A method that allows easy characterization of tumor-infiltrating lymphocytes ↗

  Journal of Immunological Methods · 2001 · PMID 11384678
  not yet assessed
• The Natural T-Helper Cell Epitope Repertoire is Unlikely to Contain Glycopeptides with Extended Carbohydrate Side-Chains ↗

  2001
  not yet assessed
• Vaccines: Presentation ↗

  Encyclopedia of Life Sciences · 2001
  not yet assessed
• Viral Recombinant Vaccines to the E6 and E7 Antigens of HPV-16 ↗

  Virology · 2000 · PMID 10772987
  not yet assessed
• In situ stimulation of a T helper cell hybridoma with a cellulose-bound peptide antigen ↗

  Journal of Immunological Methods · 2000 · PMID 10648860
  not yet assessed
• Staining of antigen activated lymphocytes (SAAL): a highly specific method for flow cytometric quantitation of tumor-specific CD8+ T cells ↗

  Journal of Immunological Methods · 2000 · PMID 10915855
  not yet assessed
• Induction of Genital Immunity by DNA Priming and Intranasal Booster Immunization with a Replication-Defective Adenoviral Recombinant ↗

  The Journal of Immunology · 1999 · PMID 10352290
  not yet assessed
• Basis of rabies virus neurovirulence in mice: expression of major histocompatibility complex class I and class II mRNAs ↗

  Journal of NeuroVirology · 1999 · PMID 10568885
  not yet assessed
• Cytotoxic T-Lymphocyte Target Proteins and Their Major Histocompatibility Complex Class I Restriction in Response to Adenovirus Vectors Delivered to Mouse Liver ↗

  Journal of Virology · 1998 · PMID 9525615
  not yet assessed
• Effect of Passive Immunization or Maternally Transferred Immunity on the Antibody Response to a Genetic Vaccine to Rabies Virus ↗

  Journal of Virology · 1998 · PMID 9499029
  not yet assessed
• A monoclonal antibody to a multiphosphorylated, conformational epitope at the carboxy-terminus of p53 ↗

  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1998 · PMID 9739174
  not yet assessed
• Genetic vaccines — a revolution in vaccinology? ↗

  Principles and practice · 1998
  not yet assessed
• The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus ↗

  Journal of Virology · 1997 · PMID 9094641
  not yet assessed
• Immune Response to Neonatal Genetic Immunization ↗

  Virology · 1997 · PMID 9123835
  not yet assessed
• Genetic vaccines — a revolution in vaccinology? ↗

  Springer Seminars in Immunopathology · 1997 · PMID 9406351
  not yet assessed
• Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. ↗

  PubMed · 1996 · PMID 8867861
  not yet assessed
• A Replication-Defective Human Adenovirus Recombinant Serves as a Highly Efficacious Vaccine Carrier ↗

  Virology · 1996 · PMID 8623532
  not yet assessed
• Novel vaccine approaches ↗

  The Journal of Immunology · 1996 · PMID 8621889
  not yet assessed
• Poly(DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines ↗

  Vaccine · 1996 · PMID 8843629
  not yet assessed
• The effects of post-translational side-chain modifications on the stimulatory activity, serum stability and conformation of synthetic peptides carrying T helper cell epitopes ↗

  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1996 · PMID 8781544
  not yet assessed
• Genetic Immunization ↗

  Viral Immunology · 1996 · PMID 8733914
  not yet assessed
• Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses ↗

  Journal of Virology · 1995 · PMID 7884845
  not yet assessed
• Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. ↗

  Proceedings of the National Academy of Sciences · 1995 · PMID 7638177
  not yet assessed
• Immune Responses to Nucleic Acid Vaccines to Rabies Virus ↗

  Virology · 1995 · PMID 7778289
  not yet assessed
• Immune Effector Mechanisms Required for Protection to Rabies Virus ↗

  Virology · 1995 · PMID 8553540
  not yet assessed
• Comparison of the effects of amino acid substitutions and β-N- vs. α-O-glycosylation on the T-cell stimulatory activity and conformation of an epitope on the rabies virus glycoprotein ↗

  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1995 · PMID 7540044
  not yet assessed
• Plasmid Vectors as Anti‐Viral Vaccinesa ↗

  Annals of the New York Academy of Sciences · 1995 · PMID 8546415
  not yet assessed
• MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses ↗

  Immunity · 1994 · PMID 7533647
  not yet assessed
• Vaccination with a Plasmid Vector Carrying the Rabies Virus Glycoprotein Gene Induces Protective Immunity against Rabies Virus ↗

  Virology · 1994 · PMID 8116236
  not yet assessed
• Immunomodulatory Activity of Monoclonal Anti-Idiotypic Antibody to Anti-Colorectal Carcinoma Antibody CO17–1A in Animals and Patients ↗

  Journal of Immunotherapy · 1994 · PMID 8061902
  not yet assessed
• Glycosylation of synthetic T helper cell epitopic peptides influences their antigenic potency and conformation in a sugar location-specific manner ↗

  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1994 · PMID 7524686
  not yet assessed
• A simple method to test the ability of individual viral proteins to induce immune responses ↗

  Journal of Virological Methods · 1994 · PMID 8051219
  not yet assessed
• Posttranslational side chain modification of a viral epitope results in diminished recognition by specific T cells ↗

  Journal of Virology · 1992 · PMID 1376365
  not yet assessed
• Immune response to the nominal phosphoprotein of rabies virus ↗

  Virus Research · 1992 · PMID 1534957
  not yet assessed
• Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine. ↗

  Proceedings of the National Academy of Sciences · 1991 · PMID 2000406
  not yet assessed
• Identification of an immunodominant epitope within the phosphoprotein of rabies virus that is recognized by both class I- and class II-restricted T cells ↗

  Journal of Virology · 1991 · PMID 1717708
  not yet assessed
• Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine ↗

  Journal of Virology · 1990 · PMID 1695255
  not yet assessed
• Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein ↗

  Journal of Virology · 1989 · PMID 2470920
  not yet assessed
• Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies. ↗

  Journal of Clinical Investigation · 1989 · PMID 2760222
  not yet assessed
• The extracellular matrix of Volvox carteri: molecular structure of the cellular compartment. ↗

  The Journal of Cell Biology · 1989 · PMID 2689458
  not yet assessed
• Anti-Idiotypic Antibodies as Vaccines to a Murine Sendai Virus Infection ↗

  Viral Immunology · 1989 · PMID 2558667
  not yet assessed
• T and B cell antigenic determinants of ribonucleoprotein (RNP) of rabies and rabies-related viruses — their relevance in the induction of protective immunity ↗

  Virus Research · 1988
  not yet assessed
• Use of T Cell‐Specific Anti‐idiotypes to Immunize against Viral Infections ↗

  Immunological Reviews · 1986 · PMID 3009303
  not yet assessed
• Induction of Anti-Viral Immunity by an Anti-Idiotypic Antibody Directed to a Sendai Virus Specific T Helper Cell Clone ↗

  International Reviews of Immunology · 1986 · PMID 2855338
  not yet assessed
• Cell receptors for the mammalian reovirus. IV. Reovirus-specific cytolytic T cell lines that have idiotypic receptors recognize anti-idiotypic B cell hybridomas. ↗

  The Journal of Immunology · 1985 · PMID 2579153
  not yet assessed
• Sendai virus-specific T-cell clones: induction of cytolytic T cells by an anti-idiotypic antibody directed against a helper T-cell clone. ↗

  Proceedings of the National Academy of Sciences · 1984 · PMID 6326148
  not yet assessed
• Sendai virus-specific T cell clones. V. Induction of a virus-specific response by antiidiotypic antibodies directed against a T helper cell clone. ↗

  The Journal of Experimental Medicine · 1984 · PMID 6327875
  not yet assessed
• Characteristics and functions of Sendai virus-specific T-cell clones ↗

  Journal of Virology · 1984 · PMID 6323742
  not yet assessed
• Sendai virus‐specific T cell clones. II. Induction of interferon production by Sendai virus‐specific T helper cell clones ↗

  European Journal of Immunology · 1982 · PMID 6297920
  not yet assessed
• Identification of idiotypic receptors on reovirus-specific cytolytic T cells. ↗

  Proceedings of the National Academy of Sciences · 1982 · PMID 6984189
  not yet assessed
• An Analysis of Effector T Cell Generation and Function in Mice Exposed to Influenza A or Sendai Viruses ↗

  Immunological Reviews · 1981 · PMID 6273293
  not yet assessed
• Cell-mediated cytotoxicity against sendai-virus-infected cells ↗

  Zeitschrift für Immunitätsforschung Immunobiology · 1976 · PMID 60844
  not yet assessed
• Modification of H-2 Antigenic Sites by Enzymatic Treatment Influences Virus-Specific Target Cell Lysis ↗

  The Journal of Immunology · 1976 · PMID 993596
  not yet assessed
• Cytotoxic interactions of virus-specific effector cells with virus-infected targets of different cell type [proceedings]. ↗

  PubMed · 1976 · PMID 1087249
  not yet assessed